1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980–1999. JAMA. 2003; 290:2968–2975.
Article
2. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013; 62:131–135.
Article
3. Choe YJ, Park YJ, Jung C, Bae GR, Lee DH. National pertussis surveillance in South Korea 1955–2011: epidemiological and clinical trends. Int J Infect Dis. 2012; 16:e850–4.
Article
4. The Korean Pediatric Society. DTaP, Tdap, Td vaccine. In : Lee HJ, editor. Immunization guideline. 8th ed. Seoul: The Korean Pediatric Society;2015. p. 187–202.
Article
5. Kim IS, Seo YB, Hong KW, Noh JY, Choi WS, Song JY, et al. Perceptions of tetanus-diphteria-acellular pertussis (Tdap) vaccination among Korean women of childbearing age. Infect Chemother. 2013; 45:217–224.
Article
6. Ministry of Health and Welfare. Korea Centers for Disease Control & Prevention. Infectious Diseases Surveillance Yearbook, 2017. Cheongju: Korea Centers for Disease Control & Prevention;2018.
Article
7. Choe YJ, Kim JW, Park YJ, Jung C, Bae GR. Burden of pertussis is underestimated in South Korea: a result from an active sentinel surveillance system. Jpn J Infect Dis. 2014; 67:230–232.
Article
8. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis. 2014; 209:978–981.
Article
9. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014; 384:1521–1528.
Article
10. Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011; 204:334.e1–334.e5.
Article
11. Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J. 2011; 30:608–610.
Article
12. Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis. 2017; 64:9–14.
Article
13. Winter K, Nickell S, Powell M, Harriman K. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017; 64:3–8.
Article
14. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA. 2014; 312:1897–1904.
Article
15. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ. 2014; 349:g4219.
Article
16. Moro PL, McNeil MM, Sukumaran L, Broder KR. The Centers for Disease Control and Prevention's public health response to monitoring Tdap safety in pregnant women in the United States. Hum Vaccin Immunother. 2015; 11:2872–2879.
Article
17. Choi WS, Choi JH, Kwon KT, Seo K, Kim MA, Lee SO, et al. Revised adult immunization guideline recommended by the Korean society of infectious diseases, 2014. Infect Chemother. 2015; 47:68–79.
Article
18. Seo J, Lim J. Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: effect of public health policies on vaccination behavior. Vaccine. 2018; 36:3666–3673.
Article
19. Noh JY, Seo YB, Song JY, Choi WS, Lee J, Jung E, et al. Perception and attitudes of Korean obstetricians about maternal influenza vaccination. J Korean Med Sci. 2016; 31:1063–1068.
Article